MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics-Reference-Cited by-同舟云学术

MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics

Published:2017-06-11 Issue:7 Volume:21 Page:671-683
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Tilstam Pathricia V.¹,Qi Dake¹²,Leng Lin¹,Young Lawrence¹,Bucala Richard¹

Affiliation:

1. Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA

2. Department of Biomedical Sciences, Memorial University of Newfoundland, St. John’s, Canada

Funder

Arthritis Foundation

NIH

MRF

RDC

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2017.1336227

Reference127 articles.

1. The changing face of cardiovascular disease 2000–2012: An analysis of the world health organisation global health estimates data

2. A nationwide framework for surveillance of cardiovascular and chronic lung diseases. Washington (DC); The National Academies Press. 2011. (The National Academies Collection: Reports funded by National Institutes of Health).

3. Chronic Coronary Artery Disease: Diagnosis and Management

4. Progress and challenges in translating the biology of atherosclerosis

5. Inflammation and plaque vulnerability

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid Cells in Myocardial Ischemic Injury: The Role of the Macrophage Migration Inhibitory Factor;Life;2024-08-05

2. Single-nucleus transcriptomics reveal cardiac cell type-specific diversification in metabolic disease transgenic pigs;iScience;2024-06

3. A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation;Metabolism;2024-04

4. Macrophage migration inhibitory factor: A noval biomarker upregulates in myasthenia gravis and correlates with disease severity and relapse;Cytokine;2024-03

5. Impact of the MIF -173G/C variant on cardiovascular disease risk: a meta-analysis of 9,047 participants;Frontiers in Cardiovascular Medicine;2024-02-26